NYSE MKT LLC · ARMP
+15.38% · +$0.6800 · Vol 111.5K
Market closed · last close 4:00 PM ET · price as of 20:00:00 ET
Armata Pharmaceuticals Inc

Armata Pharmaceuticals Inc

Biotechnology
$5.10
Card
Relationship Map

Veridion Score

BETALOW CONF · 5/6 factorsMethodology
Sentiment absence reason unknown
ARMP
Armata Pharmaceuticals Inc
Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
AVOID

Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.

27/ 100
Veridion Score
AVOID · LOW confidence
Sovereign · $25/mo
See why this score moved.
  • · Factor breakdown with raw signals
  • · Day-over-day delta + driver
  • · Factor coverage readout
  • · Valuation · hype · market flow
  • · Pro Chart event markers
  • · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: LOW · 5/6 factors with data · Fri Aug 21 · last completed session · Markets closed · resumes Mon 9:30 ET
Share on X →
Veridion Score History · 90D
Loading score history
AI Analysis
Sovereign

Why is ARMP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
Loading ARMP catalysts
About Armata Pharmaceuticals Inc
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Listed since
1994
Employees
61
Country
US

Armata Pharmaceuticals Inc is a late clinical-stage biotechnology company focused on the development of high-purity and potent, pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat bacterial infections using proprietary bacteriophage-based technology. It has completed three Phase 2 clinical trials to date. The Company operates and manages its business as one reportable operating segment, which is the business of developing pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat acute and chronic bacterial infections using its proprietary bacteriophage-based technology.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$4.42
Day high
$5.10
Day low
$4.42
Previous close
$4.42
52W high
$14.80
-65.54% from high
52W low
$2.44
22% of range
Market cap
$189.6M
EPS
$-4.6200
Beta
-1.22
Shares out
37.2M
Volume
111.5K
0.77× rel vol
Avg volume
144.6K
VWAP
$4.81
Price history computed in-house
1W
+13.84%
1M
+9.44%
3M
-37.58%
1Y
+90.30%
YTD
-18.79%
SMA 50 $5.34 · below
SMA 200 $7.55 · below
52W position 22%

ARMP overview

Veridion Score
27
Registered · 2026-08-21
5 of 6 factors measured
Latest receipt rows
0
No recent disclosure on file.
13F holders
None on file

Related filings and maps

Relationship mapTrace receipt-backed holders and filings around ARMP.Congress trackerSearch the public STOCK Act disclosure ledger.MethodologyReview score inputs, coverage rules, and limitations.
Loading financial statements
Loading ARMP Form 4 filings
Public disclosures

Congress activity in ARMP

Congress trackerOpen ticker disclosure ledger →

No receipt-qualified Congressional disclosure is present for ARMP in the cached public ledger.

Federal contracts

ARMP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ARMP in this window.
Lobbying spend

ARMP lobbying filings, year to date.

Registered lobbying filings matched to Armata Pharmaceuticals Inc.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ARMP in this window.
Loading news for ARMP
Analyst ratings
Sovereign unlock shows live analyst consensus for ARMP.
Options
Sovereign unlock shows live options positioning for ARMP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.